simon Xi is the founder of Rgenta Therapeutics. Rgenta Therapeutics has raised $90M in total funding. Latest round: Series A. Based in Woburn, MA.
Simon Xi, Ph.D., is the Co-founder and CEO of Rgenta Therapeutics, a biotechnology company focused on developing RNA-targeting medicines for historically undruggable disease targets. He has led the company since its founding in December 2019, overseeing the development of novel oral small molecules.
Full founder directory · Investor directory · Company funding database · Fundraising library